Development of a Risk Score for Geographic Atrophy in Complications of the Age-related Macular Degeneration Prevention Trial
Authors:
- Gui-Shuang YingGYGui-Shuang Ying
- Maureen G. MaguireMMMaureen G. Maguire
- 1 February 2011
- journal article
- research article
- Published by Elsevier in Ophthalmology
- Vol. 118 (2) , 332-338
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Eye Institute
- U.S. Department of Health and Human Services
This publication has 34 references indexed in Scilit:
- Description of the Age-Related Eye Disease Study 9-Step Severity Scale Applied to Participants in the Complications of Age-related Macular Degeneration Prevention TrialArchives of Ophthalmology (1950), 2009
- Risk Factors for Choroidal Neovascularization and Geographic Atrophy in the Complications of Age-Related Macular Degeneration Prevention TrialOphthalmology, 2008
- Smoking and the Risk of Age-related Macular Degeneration: A Meta-AnalysisAnnals of Epidemiology, 2008
- Ranibizumab versus Verteporfin for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2006
- Ranibizumab for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2006
- The Age-Related Eye Disease Study Severity Scale for Age-Related Macular DegenerationArchives of Ophthalmology (1950), 2005
- Risk Factors for the Incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS)AREDS report no. 19Ophthalmology, 2005
- Prevalence of Age-Related Macular Degeneration in the United StatesArchives of Ophthalmology (1950), 2004
- Risk factors for age-related macular degenerationOphthalmology, 2001
- Evolution of geographic atrophy of the retinal pigment epitheliumEye, 1988